Science Translational Medicine · 2012 · 147 citations · 42 references
Veterinary MedicineImmunologyInfectious DiseasesAdaptive ImmunityImmunizationVaccinologyImmune Response To VaccinationMammalian ImmunologyProtective ImmunitySusceptibility To InfectionVaccinationVeterinary ImmunologyAnimal ImmunizationEbola VaccinesEfficacy Against InfectionHost-pathogen Interactions In RodentsImmunogenicity Correlates Of ProtectionMechanisms Of Vaccine-induced ProtectionPrimate Infectious DiseasesProtective Correlates Of Immunity
Ebola virus causes severe hemorrhagic fever in susceptible hosts. Currently, no licensed vaccines or treatments are available; however, several experimental vaccines have been successful in protecting rodents and nonhuman primates (NHPs) from the lethal Zaire ebolavirus (ZEBOV) infection. The objective of this study was to evaluate immune responses correlating with survival in these animals after lethal challenge with ZEBOV. Knockout mice with impaired ability to generate normal T and/or B cell responses were vaccinated and challenged with ZEBOV. Vaccine-induced protection in mice was mainly mediated by B cells and CD4(+) T cells. Vaccinated, outbred guinea pigs and NHPs demonstrated the highest correlation between survival and levels of total immunoglobulin G (IgG) specific to the ZEBOV glycoprotein (ZGP). These results highlight the relevance of total ZGP-specific IgG levels as a meaningful correlate of protection against ZEBOV exposure.
42
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee, Marnie L. Fusco, Ann J. Hessell et al. · Nature · 2008 · 740 citations · Full text
Development of a preventive vaccine for Ebola virus infection in primates
Nancy J. Sullivan, Anthony Sanchez, Pierre E. Rollin et al. · Nature · 2000 · 661 citations